Immediate Impact
14 standout
Citing Papers
Cell death, therapeutics, and the immune response in cancer
2023 Standout
Frailty and Cancer: Current Perspectives on Assessment and Monitoring
2023 Standout
Works of Alice R.T. Bergin being referenced
Risk of febrile neutropenia and early treatment cessation in men receiving standard and dose‐reduced 3‐weekly docetaxel for metastatic castration‐resistant prostate cancer
2018
Safety and efficacy of the BCL2 inhibitor venetoclax in estrogen receptor (ER) and BCL2-positive metastatic breast cancer: The mBEP study.
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alice R.T. Bergin | 15 | 15 | 5 | 12 | 8 | 39 | |
| Jamil Asselah | 17 | 21 | 6 | 17 | 9 | 48 | |
| Wei Gao | 21 | 25 | 9 | 9 | 8 | 57 | |
| Johan Verschuere | 18 | 13 | 4 | 18 | 6 | 50 | |
| Cora A. Ricker | 17 | 13 | 5 | 17 | 8 | 41 | |
| Sarah Derby | 15 | 17 | 3 | 13 | 9 | 39 | |
| Martina Milighetti | 10 | 15 | 6 | 22 | 7 | 48 | |
| Zhijian Zheng | 16 | 10 | 9 | 10 | 7 | 37 | |
| Laura Horsley | 13 | 13 | 6 | 17 | 6 | 35 | |
| Lanie E. Happ | 9 | 18 | 8 | 9 | 9 | 40 | |
| Valentina Bonuomo | 6 | 22 | 3 | 10 | 7 | 48 |
All Works
Login with ORCID to disown or claim papers
Loading papers...